Company Overview

WuXi Biologics provides an end-to-end technology platform enabling partners to discover, develop, and manufacture biologics from concept to commercialization.

Their single-use bioreactor facilities and continuous bioprocessing technologies offer flexible manufacturing scale for monoclonal antibodies, bispecifics, and antibody-drug conjugates (ADCs).

With commercial-scale manufacturing facilities globally, WuXi Biologics supplies clinical and commercial programs under strict cGMP adherence.